✦ LIBER ✦

A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas

✍ Scribed by Patrick A. Burch; Albert M. Bernath; Terrence L. Cascino; Bernd W. Scheithauer; Paul Novotny; Suresh Nair; Jan C. Buckner; Delano M. Pfeifle; John W. Kugler; Loren K. Tschetter

Book ID: 110235432
Publisher: Springer US
Year: 2000
Tongue: English
Weight: 59 KB
Volume: 18
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1006438109266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of two different irinotec

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

✍ Marta Santisteban; Jan C. Buckner; Joel M. Reid; Wenting Wu; Bernd W. Scheithaue 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 235 KB

Thalidomide therapy in adult patients wi

Thalidomide therapy in adult patients with myelodysplastic syndrome : A North Central Cancer Treatment Group phase II trial

✍ Alvaro Moreno-Aspitia; Gerardo Colon-Otero; Antje Hoering; Ayalew Tefferi; Rober 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. Thalidomide has shown promise for the treatment of patients with myelodysplastic syndrome. The current prospective multicenter study examined the efficacy and toxicity of thalidomide in adult patients with myelodysplastic syndrome. ## METHODS. Using the International P

Thalidomide therapy in adult patients wi

Thalidomide therapy in adult patients with myelodysplastic syndrome : A North Central Cancer Treatment Group phase II trial

✍ Pellegrino Musto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Low-dose, single-agent temsirolimus for

Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma : A phase 2 trial in the North Central Cancer Treatment Group

✍ Stephen M. Ansell; David J. Inwards; Kendrith M. Rowland Jr.; Patrick J. Flynn; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Phase II trial of vorinostat in combinat

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

✍ Friday, B. B.; Anderson, S. K.; Buckner, J.; Yu, C.; Giannini, C.; Geoffroy, F.; 📂 Article 📅 2011 🏛 Duke University Press 🌐 English ⚖ 174 KB

Phase II trial of topotecan in advanced

Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study

✍ Jacqueline K. Benedetti; Howard A. Burris III; Stanley P. Balcerzak; John S. Mac 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 22 KB